Vyome Holdings, Inc. (Nasdaq: HIND) ("Vyome"), a clinical-stage biopharmaceutical company focused on immuno-inflammatory and rare disease conditions, today congratulated its Scientific Co-Founder and ...
Vyome Holdings, Inc. (Nasdaq: HIND), a Cambridge, Massachusetts-based clinical-stage biopharmaceutical company, announced ...
The first edition received 156 submissions from 29 countries and awards US$5,000 in unrestricted cash prizes, alongside 16 ...
Discover expert insights into single-cell proteomics, revealing protein diversity and non-canonical biology with advanced mass spectrometry ...
A five-year, up-to-$29.6 million research consortium will develop living cardiac tissues for infants and young children with ...
The nation was distracted by other things when a quiet warning sounded: Support was diminishing for American academic ...
This is the Fall 2026 Membership Meeting of the Forum on Neuroscience and Nervous System Disorders. Members will receive an ...
Planning for Tamil Nadu engineering admission in 2027? Check TNEA registration, eligibility, rank list, counselling schedule and seat allotment updates.
Dear members of the Columbia community, I write to provide a brief update on the search for the next executive vice president ...
Die meisten von uns kennen dieses Gefühl am Ende eines langen Arbeitstages. Sie stehen von Ihrem Schreibtisch auf, und Ihr ...
25 Jahre interdisziplinäre biomedizinische Forschung am MIBE der TUM: von innovativer Bildgebung und Organoidsystemen bis zur ...
Una nueva formulación farmacéutica en forma de gel diseñada por ingenieros del MIT puede recubrir la mucosa esofágica y ...